open access
Acute management of paroxysmal atrial fibrillation with beta blockers plus intrave-nous flecainide: A real-world Chios registry (BETAFLEC-CHIOS)
Affiliations- Department of Cardiology, Skylitseio General Hospital of Chios, Chios, Greece
- Department of Cardiology, Henri Dunant Hospital, Athens, Greece
- 1st Department of Cardiology, AHEPA University General Hospital, Thessaloniki, Greece
open access
Abstract
Abstract
Supp./Additional Files (1)
About this articleTitle
Acute management of paroxysmal atrial fibrillation with beta blockers plus intrave-nous flecainide: A real-world Chios registry (BETAFLEC-CHIOS)
Journal
Kardiologia Polska (Polish Heart Journal)
Issue
Article type
Short communication
Published online
2022-11-23
Page views
67
Article views/downloads
32
DOI
10.33963/KP.a2022.0267
Pubmed
Authors
Athanasios Kartalis
Dimitrios Afendoulis
Maria Moutafi
Petros Voutas
Nikolaos Papagiannis
Stefanos Garoufalis
Nikolaos Kartalis
Nikolaos Smyrnioudis
Georgios Andrikopoulos
Matthaios Didagelos
References (7)- Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021; 42(5): 373–498.
- Aliot E, Capucci A, Crijns HJ, et al. Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation. Europace. 2011; 13(2): 161–173.
- Madrid AH, Moro C, Marín-Huerta E, et al. Comparison of flecainide and procainamide in cardioversion of atrial fibrillation. Eur Heart J. 1993; 14(8): 1127–1131.
- Martı́nez-Marcos F, Garcı́a-Garmendia J, Ortega-Carpio A, et al. Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. The American Journal of Cardiology. 2000; 86(9): 950–953.
- Schnaubelt S, Domanovits H, Niederdoeckl J, et al. The Impact of the COVID-19 Pandemic on Incidences of Atrial Fibrillation and Electrical Cardioversion at a Tertiary Care Emergency Department: An Inter- and Intra-year Analysis. Front Med (Lausanne). 2020; 7: 595881.
- Ermakov S, Gerstenfeld EP, Svetlichnaya Y, et al. Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2017; 14(4): 564–569.
- Wybraniec MT, Maciąg A, Miśkowiec D, et al. Efficacy and safety of antazoline for cardioversion of atrial fibrillation: propensity score matching analysis of a multicenter registry (CANT II Study). Pol Arch Intern Med. 2022; 132(6).
